Phase
Condition
Toenail Fungus (Onychomycosis)
Treatment
Trichostatin A
Clinical Study ID
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Willingness to provide signed and dated written voluntary informed consent.
Adults with diagnosis of mild-to-severe DLSO/DSO affecting at least one greattoenail.
Positive microscopic examination with KOH for dermatophyte hyphae.
Positive dermatophyte culture or mixed dermatophyte/Candida culture.
Exclusion
Exclusion Criteria:
Presence of other toenail infection.
Any disease or condition that may interfere with the evaluation including otherconditions that affect the toenails or significant active tinea pedis.
History of other significant chronic fungal disease, psoriasis, lichen planus or useof drug medications for those indications 6 months prior to screening and during thestudy.
Participation in a previous clinical trial 3 months prior to screening orparticipation in a research study concurrent with this study.
Current or planned pregnancy during the trial period.
Study Design
Connect with a study center
Vanda Investigational Site
Fremont, California 94538
United StatesSite Not Available
Vanda Investigational Site
Fremont 5350734, California 5332921 94538
United StatesActive - Recruiting
Vanda Investigational Site
Denver 5419384, Colorado 5417618 80210
United StatesActive - Recruiting
Vanda Investigational Site
New Brighton, Minnesota 55112
United StatesSite Not Available
Vanda Investigational Site
New Brighton 5039080, Minnesota 5037779 55112
United StatesActive - Recruiting
Vanda Investigational Site
Austin, Texas 78759
United StatesSite Not Available
Vanda Investigational Site
Pflugerville 4718711, Texas 4736286 78660
United StatesActive - Recruiting
Vanda Investigational Site
Forest 4759556, Virginia 6254928 24551
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.